SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-045353
Filing Date
2024-11-14
Accepted
2024-11-14 08:00:39
Documents
34
Period of Report
2024-11-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38115
2 ex99-1.htm EX-99.1 15181
3 ex99-1_001.jpg GRAPHIC 502932
4 ex99-1_002.jpg GRAPHIC 717867
5 ex99-1_003.jpg GRAPHIC 1356599
6 ex99-1_004.jpg GRAPHIC 834149
7 ex99-1_005.jpg GRAPHIC 561610
8 ex99-1_006.jpg GRAPHIC 772523
9 ex99-1_007.jpg GRAPHIC 685006
10 ex99-1_008.jpg GRAPHIC 610438
11 ex99-1_009.jpg GRAPHIC 735957
12 ex99-1_010.jpg GRAPHIC 714849
13 ex99-1_011.jpg GRAPHIC 1130492
14 ex99-1_012.jpg GRAPHIC 809475
15 ex99-1_013.jpg GRAPHIC 866452
16 ex99-1_014.jpg GRAPHIC 668861
17 ex99-1_015.jpg GRAPHIC 415773
18 ex99-1_016.jpg GRAPHIC 282769
19 ex99-1_017.jpg GRAPHIC 846392
20 ex99-1_018.jpg GRAPHIC 551515
21 ex99-1_019.jpg GRAPHIC 602046
  Complete submission text file 0001493152-24-045353.txt   19008958

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE pvct-20241114.xsd EX-101.SCH 3027
23 XBRL LABEL FILE pvct-20241114_lab.xml EX-101.LAB 34240
24 XBRL PRESENTATION FILE pvct-20241114_pre.xml EX-101.PRE 24173
37 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3363
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 241457290
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)